LENSRXLAB secures $830,000 in seed funding to develop two B2B Healthcare Delivery Platforms and Advanced Lens Technology for Diabetics.

LENSRXLAB, founded by Anthony B. Miles and Dr. Chelise Firmin, has secured $830,000 in seed funding to develop two B2B Healthcare Delivery Platforms and a proprietary Advanced Lens Technology for Diabetics. The funding will be used to go to market with the platforms at scale, production of inventory, hiring key staff, and equity toward the build-out and automated production equipment for its manufacturing facility in Philadelphia, Pennsylvania.